| Time | Nov.4-8, 2026 |
| Location | Phoenix, AZ, USA |
| Company | DIMA BIOTECH |
| Booth | #1033 |
Meet DIMA BIOTECH at SITC 2026
DIMA BIOTECH (hereafter referred to as “DIMA”) is pleased to announce its participation in the SITC 2026, where we will showcase the latest advancements in Nanodisc technology platforms, multi-pass transmembrane protein research tools, and therapeutic monoclonal antibody development.
The Society for Immunotherapy of Cancer (SITC) Annual Meeting is one of the leading global conferences dedicated to advancing cancer immunology and immunotherapy. SITC 2026 will bring together researchers, clinicians, industry leaders, and translational scientists to discuss the latest breakthroughs in cancer immunotherapy, including emerging therapeutic strategies, immune engineering technologies, biomarker discovery, and clinical translation.
Through scientific presentations, poster sessions, industry exhibitions, and networking opportunities, SITC 2026 provides a platform for collaboration across academia, biotechnology, and pharmaceutical industries.
DIMA will participate in SITC 2026 with an exhibition booth.Visitors are also welcome to meet our team at Booth #1033 to learn more about our membrane protein platforms, antibody discovery capabilities, and solutions for challenging drug targets.
DIMA will participate in SITC 2026 through an exhibition booth and a scientific poster. Visit us at Booth #1033 to explore our integrated research platform for drug discovery, including our Nanodisc Membrane Protein Platforms and Ready-to-Test Lead mAbs, designed to support antibody discovery and development against challenging targets.
We will also present a poster entitled “The Application of Nanodisc Technology Platform to Develop Therapeutic mAbs for Multi-Pass Transmembrane Protein Targets,” highlighting how our Nanodisc technology enables the development of high-quality, native-like membrane protein targets and facilitates therapeutic antibody discovery against complex multi-pass transmembrane proteins. We look forward to connecting with researchers and industry partners to explore innovative solutions for challenging drug targets.
Booth
The location of DIMA BIOTECH’s booth
Poster
DIMA's Features
DiMProTM Nanodisc Membrane Protein Platforms
- Full-length GPCR proteins in native conformation
- Ion channel and multi-pass membrane protein solutions
- Stable and functional protein formats for drug discovery
- 700+ Nanodisc proteins, with 500+ in stock
Ready-to-Test Lead mAbs for Therapeutic Targets
- 5000+ Pre-validated IgG Sequences, 500+ Druggable Targets
- Zero Upfront, Zero Waiting, Zero Risk
- Functional Evaluation on Different Modality Platforms (CAR-T, ADC, BsAb, etc.)
- Mammalian Cell Display Based Antibody Engineering Platform for lead mAbs Optimization
Come learn more about our studies and connect with us at booth #207. We look forward to meeting you there!
Schedule a meeting with Us!Products
Resources
A case of Nanodisc Used in mAbs Development as Immunogen
Pick Out Your Gifts on Our Booth (#1033)
Schedule a Meeting with Our Team
Complete the form to receive exclusive offers.
- ⚡ 24h response
- 🌍 Trusted by global researchers